2m 2m 2m 2m 2m 2m 2m
RALLYBIO (RLYB)
NASDAQ
$15.68-$0.02 (-0.16%)
Price as of Jun 23, 2026 5:07 PM EDT- $92.4MMarket Cap
- 538.43%1-Year Change
- BiotechnologyIndustry
RALLYBIO (RLYB)
$15.68-$0.02 (-0.16%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 858,000 +43.00% | 600,000 N/A | N/A N/A | N/A N/A | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 858,000 +43.00% | 600,000 N/A | 0 N/A | 0 N/A | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -19.6M -52.79% | -41.5M -22.48% | -53.5M +31.59% | -40.7M +51.21% | |
Depreciation and Amortization Expense | 92,000 -29.77% | 131,000 -12.67% | 150,000 -10.18% | 167,000 +53.21% | |
Total Operating Expenses | 33.9M -44.51% | 61.1M -22.55% | 78.9M +16.27% | 67.9M +48.71% | |
Operating Profit | -33.1M -45.35% | -60.5M -23.36% | -78.9M +16.27% | -67.9M +48.71% | |
Interest Income | 2.2M -48.08% | 4.2M -31.41% | 6.1M +213.14% | 2.0M +3,535.19% | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | 0 +100.00% | |
Interest Income and Expense and Net | 2.2M -48.08% | 4.2M -31.41% | 6.1M +213.14% | 2.0M +4,361.36% | |
Total Nonoperating Income and Expense | 25.0M +403.23% | 5.0M -22.61% | 6.4M +178.05% | 2.3M +1,546.43% | |
Income before Taxes | -8.1M -85.41% | -55.5M -23.42% | -72.5M +10.59% | -65.6M +44.10% | |
Income Taxes | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -9.0M -84.46% | -57.8M -22.52% | -74.6M +11.87% | -66.7M +41.78% | |
Net Income from Continuing Operations Applicable to Common | -9.0M -84.46% | -57.8M -22.52% | -74.6M +13.70% | -65.6M +44.10% | |
Basic EPS and Net Income | -1.59 +19.55% | -1.33 -27.72% | -1.84 -11.96% | -2.09 +13.59% | |
Diluted EPS and Net Income | -1.59 +19.55% | -1.33 -27.72% | -1.84 -11.96% | -2.09 +13.59% | |
Basic Weighted Average Shares | 5.6M -87.07% | 43.5M +7.66% | 40.4M +27.11% | 31.8M +24.70% | |
Diluted Weighted Average Shares | 5.6M -87.07% | 43.5M +7.66% | 40.4M +27.11% | 31.8M +24.70% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 31.4M +125.66% | 13.9M -43.24% | 24.5M -57.00% | 57.0M -67.51% | |
Short-Term Investments | 23.4M -54.73% | 51.6M -39.59% | 85.4M -23.74% | 112.0M N/A | |
Cash and Cash Equivalents and Short-Term Investments | 54.7M -16.45% | 65.5M -40.41% | 109.9M -34.95% | 169.0M -3.62% | |
Total Current Assets | 61.3M -9.71% | 67.8M -40.90% | 114.8M -36.05% | 179.5M -0.76% | |
Accumulated Depreciation | 480,000 -26.61% | 654,000 +25.05% | 523,000 +40.21% | 373,000 +81.07% | |
Property and Plant and Equipment and Net | 23,000 -80.00% | 115,000 -53.25% | 246,000 -36.10% | 385,000 -24.66% | |
Total Long-Term Assets | 810,000 +604.35% | 115,000 -53.25% | 246,000 -36.10% | 385,000 -24.66% | |
Total Assets | 62.3M -8.58% | 68.1M -41.09% | 115.6M -35.92% | 180.4M -0.96% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 4.2M -32.35% | 6.2M -32.61% | 9.3M -13.78% | 10.7M +64.01% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 82,000 -61.32% | 212,000 +22.54% | 173,000 -53.74% | 374,000 N/A | |
Total Liabilities | 4.3M -33.30% | 6.5M -31.60% | 9.4M -15.13% | 11.1M +68.89% | |
Retained Earnings | -302.0M +3.06% | -293.0M +24.56% | -235.2M +46.40% | -160.7M +70.89% | |
Total Stockholders Equity | 58.0M -6.00% | 61.7M -41.94% | 106.2M -37.29% | 169.3M -3.58% | |
Total Shares Outstanding | 5.3M -87.27% | 41.5M +9.73% | 37.8M -0.02% | 37.8M +17.76% | |
Cash Flow | |||||
Cash from Operating Activities | -29.8M -39.51% | -49.3M -18.22% | -60.3M +5.20% | -57.3M +25.81% | |
Capital Expenditures | N/A N/A | 0 -100.00% | 12,000 -77.78% | 54,000 -83.78% | |
Cash from Investing Activities | 47.3M +41.13% | 33.5M +21.09% | 27.7M +124.66% | -112.2M +4,707.97% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 16,000 -99.69% | 5.2M +3,535.66% | 143,000 -99.72% | 51.1M -38.44% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -3,853.61% -61.78% | -10,082.67% N/A | N/A N/A | N/A N/A | |
Return on Assets | -13.77% -78.10% | -62.89% +24.86% | -50.37% +37.02% | -36.76% N/A | |
Return on Equity | -15.01% -78.19% | -68.85% +27.19% | -54.13% +40.05% | -38.65% N/A | |
Revenue Growth | 43.00% N/A | N/A N/A | N/A N/A | N/A N/A | |
Current Ratio | 14.50 +33.46% | 10.87 -12.30% | 12.39 -25.82% | 16.71 N/A | |
Cash Ratio | 7.43 +233.56% | 2.23 -15.77% | 2.64 -50.12% | 5.30 N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow